Dr. Colleen Cotton discusses the findings of her most recent collaborative study – Association of Demographic Factors and Infantile Hemangioma Characteristics with Risk of PHACE Syndrome. Learn more about hemangioma patterns that might suggest greater or lower risk for PHACE Syndrome and how to identify a high-risk patient for a full PHACE Syndrome work up.
Colleen Cotton, MD
Dr. Colleen Cotton is an Assistant Professor of Pediatric Dermatology and a pediatric dermatologist at the Medical University of South Carolina.
Moderate-to-severe alopecia areata (AA) is associated with negative impacts on quality of life and health outcomes in all age groups. However, the impact on children living with this disease and their families is uniquely severe. Children and their families face the daily burden of a chronic disease, exacerbated by bullying and impact on parental mental health that is particularly severe for a disease with such noticeable manifestations. Recent advances in our understanding of the pathobiology underlying AA have contributed to a promising pipeline of therapeutic options for patients in the near future. Yet, apprehension remains over the consequences of systemic treatment of AA, which is all the more significant in the pediatric population. To address the need for better awareness and understanding of AA, and provide a greater depth of knowledge in the mechanisms underlying emerging treatment options for AA, PeDRA is conducting a six-part educational series Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children.
Being hosted by distinguished faculty in pediatric dermatology this non-CME program will include a total of six parts, including three webinars, three podcasts.
Part 1: ALOPECIA AREATA – A Clinical Overview
PRESENTED LIVE: Wednesday, May 19, 2021, 5:00 – 6:00PM PT / 8:00 – 9:00PM ET
Chairs and Speakers: Leslie Castelo-Soccio MD, PhD and Britt Craiglow, MD
Part 2: ALOPECIA AREATA – The Science
PRESENTED LIVE: Wednesday, June 2, 2021, 5:00 – 6:00PM PT / 8:00 – 9:00PM ET
Chairs: Leslie Castelo-Soccio, MD, PhD and Britt Craiglow, MD
Speakers: John O’Shea, MD, and Ali Jabbari, MD, PhD
Part 3: ALOPECIA AREATA – The Future
PRESENTED LIVE: Wednesday, June 16, 2021, 5:00 – 6:00PM PT / 8:00 – 9:00PM ET
Chairs: Chairs: Leslie Castelo-Soccio, MD, PhD and
Britt Craiglow, MD
Speaker: Rodney Sinclair, MD, MBBS, FACD
Podcast Part 1: ALOPECIA AREATA – A Conversation with Dr. Carolyn Goh
Chairs: Leslie Castelo-Soccio, MD, PhD and Britt Craiglow, MD
Special Guest: Carolyn Goh, MD
Podcast Part 2: ALOPECIA AREATA – Ask Me Anything
Chairs: Britt Craiglow, MD and
Leslie Castelo-Soccio, MD, PhD
Leslie Castelo-Soccio, MD, PhD
Dr. Castelo-Soccio is Assistant Professor of Dermatology and Pediatrics at the University of Pennsylvania Perelman School of Medicine and Director of Research in the Section of Dermatology at Children’s Hospital of Philadelphia. She maintains board-certification in dermatology and pediatric dermatology. Dr. Castelo-Soccio is dedicated to patient care and research with a goal of improving quality of life for pediatric patients with skin disease. She has a clinical and academic focus on alopecia, hair conditions and genodermatoses with specialty clinics for both hair and genodermatoses. She has worked on creating tools that can be used in both the clinical and research arenas and has a research interest in the microbiome of alopecia areata. As research director for her section, she additionally supports medical students, residents, fellows and colleagues in many other areas of collaborative research. She has been supported by the Dermatology Foundation and the National Alopecia Areata Foundation. She is an active on the medical advisory board for the National Alopecia Areata Foundation and as a leader of the Hair working group for the Pediatric Dermatology Research Alliance.
Britt Craiglow, MD
Dr. Craiglow is Adjunct Associate Professor of Dermatology at Yale and sees patients in private practice in Fairfield, CT. Her clinical areas of expertise include inflammatory dermatoses, alopecia, and inherited disorders of keratinization. She has particular interest in medical therapeutics and health-related quality of life. Dr. Craiglow has been a pioneer in the use of Janus kinase inhibitors for alopecia areata and strong advocate for advancement of therapies for those affected by this often devastating disease.
Ali Jabbari, MD, PhD
Dr. Jabbari is an Associate Professor of Dermatology at the University of Iowa, where he supervises the resident-staffed Hair Disorders Clinic, serves as a Principal Investigator for the University of Iowa Alopecia Areata Registry, and runs a basic science research laboratory. The major focus of his work is inflammatory and immunoregulatory pathways in alopecia areata. Dr. Jabbari has received funding from the Dermatology Foundation, the National Institutes of Health, and the Department of Veterans Affairs.
John O’Shea, MD
John J. O’Shea graduated Phi Beta Kappa from St. Lawrence University and the University of Cincinnati College of Medicine. He carried out a residency in Internal Medicine at the SUNY-Upstate Medical University and subspecialty training and postdoctoral research at the NIH. He is currently the Director of the Intramural Research Program at the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Dr. O’Shea has made fundamental discoveries related to the basic mechanisms underlying cytokine signal transduction. He and his colleagues first cloned the human tyrosine kinase JAK3 and discovered its role in signaling by interleukin-2. These insights led to the discovery of JAK3 mutations as a cause of severe combined immunodeficiency. This led Dr. O’Shea and his colleagues to propose that targeting JAKs would represent a new class of immunomodulatory drugs and now nine JAK inhibitors been approved for the treatment of multiple forms of arthritis, atopic dermatitis and inflammatory bowel disease. Dr. O’Shea has made many important insights into the role of STAT family transcription factors and more recently, he has made seminal discoveries related to how STATs impact the epigenome.
Dr. O’Shea has received numerous awards, including the: NIH Director’s Award four times, USPHS Physician Researcher of the Year Award, Irish Immunology Public Lecture Award, Arthritis Foundation’s Howley Prize, Drake Prize, Ross Prize in Molecular Medicine, the Millstein Prize, the AAI-Steinman Award for Human Immunology and the ASCI Harrington Prize. Dr. O’Shea is a member of the American Society of Clinical Investigation, American Association of Physicians and the National Academy of Medicine and was named a Master of the American College of Rheumatology. He has published more than 330 peer-reviewed articles and is on the editorial boards of Immunity and the Journal of Experimental Medicine. ing soon
Rodney Sinclair, MD, MBBS, FACD
Rodney Sinclair is a Professorial Associate in the Department of Medicine at the University of Melbourne, Director of Sinclair Dermatology Institute for Research, Education and Clinical Trials (DIRECT) and Professor/Director of Dermatology at the Epworth Hospital, a 700+ bed, not for profit private hospital in Melbourne. He is co-founder and Past-President of the Australasian Society for Dermatology Research (ASDR), co-founder and Past-President of the Australasian Hair and Wool Research Society (AHWRS) and Past–President of the Skin and Cancer Foundation of Victoria. He is a Board Member of the International Society of Dermatology, the International Academy of Cosmetic Dermatology, the ASDR and AHWRS. He was Professor/Director of Dermatology at St Vincent’s Hospital Melbourne from 2005-2013 and in 2012 was awarded Honorary Life Membership of the American Dermatology Association. Prof Sinclair is Secretary General for the International Congress of Dermatology in Melbourne that will be held in November 2021 and Congress President of the World Congress of Hair Research that will be held in Melbourne in April 2022. In 2021 he will deliver a plenary lecture at the 101st British Association of Dermatology Annual Scientific Meeting. He has supervised over 15 post-graduate research students and co-established the PhD/FACD program in Australia develop clinician scientists. Professor Sinclair’s contributions to the medical literature can be viewed at here.
Carolyn Goh, MD
Dr. Goh is Associate Clinical Professor of Dermatology at David Geffen School of Medicine at UCLA She practices general medical dermatology with a specialty in hair loss and scalp disorders. She did undergraduate studies at Stanford University with a major in Comparative Studies in Race and Ethnicity with a minor in Human Biology. She completed medical school at Weill Medical College of Cornell University with honors in both research and community service. She did an internship in internal medicine at Harbor-UCLA Medical Center and completed her residency at New York-Presbyterian Hospital/Cornell in New York City. Her research and clinical interests are in all types of hair loss including alopecia areata and scarring alopecia. She has been active with patient advocacy groups and local support groups for patients with hair loss. Additionally, she sees children and adults for all skin disorders including eczema, psoriasis, acne, and skin cancer.
Special thanks to Pfizer Inc. for their support of this independent medical education program. PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.
Dr. Yvonne Chiu discusses the findings of her most recent collaborative study – Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations. Learn about the different morphea categories, and whether or not certain locations of linear morphea are risk factors for extracutaneous involvement.
Yvonne Chiu, MD
Dr. Yvonne Chiu is an Associate Professor of Dermatology and Pediatrics at the Medical College of Wisconsin and a staff pediatric dermatologist at the Children’s Hospital of Wisconsin.
Live webinar on Tuesday, April 27, 2021 at 5:30 PM PT / 8:30 PM ET. So you’ve got the funding, now how do you make the research happen? Hear from three funded PeDRA investigators and learn how they assembled their teams, tackled the paperwork, and got their projects off the ground. Don’t miss this great opportunity to learn from their experiences!
This program is run in partnership with the Society for Pediatric Dermatology Junior Faculty/Fellows Committee.
Catalyzing Your Research: From Idea to Action
Tuesday, April 27, 5:30 PM PT / 7:30 PM CT / 8:30 PM ET
Hosts: Lisa Arkin, MD and JiaDe Yu, MD
Speakers: Elena Hawryluk, MD, PhD, Lucinda Kohn, MD and Leo Shmuylovich, MD, PhD
Elena Hawryluk, MD, PhD
Elena B. Hawryluk, MD, PhD is a board-certified Dermatologist and Pediatric Dermatologist, and Assistant Professor of Dermatology at Harvard Medical School, where she serves as the Faculty Director of Pediatric Dermatology for the Harvard Combined Dermatology Residency Program. After graduating from Carnegie Mellon University with degrees in Computer Science and Biological Sciences, she completed her medical degree (MD) and PhD (Cell Biology and Molecular Physiology) at the University of Pittsburgh School of Medicine’s Medical Scientist Training Program. Dr. Hawryluk completed her internship at St. Vincent Hospital, followed by dermatology residency at Harvard Medical School, where she served as a Chief Resident. Subsequently, she undertook advanced fellowship training in Pediatric Dermatology at Boston Children’s Hospital and was supported by the Dermatology Foundation’s Fellowship in Pediatric Dermatology award. She serves on committees for the American Academy of Dermatology and Society for Pediatric Dermatology and is the Chair of the American Academy of Dermatology’s Melanoma and Skin Cancer Community Program Committee. Dr. Hawryluk has a clinical interest in pigmented lesions and melanoma, particularly in the pediatric population. She has authored both primary research and review articles on melanoma and pigmented lesions and has delivered presentations at regional and national meetings on these topics. She has been supported by the Society for Pediatric Dermatology and Pediatric Dermatology Research Alliance’s Weston Career Development Award and the Dermatology Foundation Pediatric Dermatology Career Development Award.
Lucinda Kohn, MD
Lucinda Kohn, MD is an Assistant Professor of Dermatology at the University of Colorado, Anschutz Medical Campus and practices pediatric dermatology at the Children’s Hospital of Colorado. Dr. Kohn’s main area of academic interest is focused on increasing access to pediatric dermatology care for all children. She is affiliated with the Centers for American Indian and Alaska Native Health at the Colorado School of Public Health and is particularly focused on addressing disparities in dermatology care in American Indian and Alaska Native populations. Her overall career goal is to develop high quality, ethical, and replicable programs to expand pediatric dermatology to American Indian and Alaska Native youth.
Leo Smuylovich, MD, PhD
Dr. Shmuylovich is a Pediatric Dermatologist in the Division of Dermatology and a postdoctoral scholar in the Optical Radiology Laboratory at Washington University in Saint Louis, Missouri. He is at the start of his career as an MD/PhD dermatology physician scientist. His training has included both a Bachelors of Science in Chemical Engineering and a Physics PhD, and inspired by his quantitative background, he is focused on developing novel tools that objectively measure skin disease. The research mission of his lab will be the development technologies that provide all patients with access to accurate diagnosis and management of skin disease and improve treatment outcomes.
This collaborative study examined the effectiveness of current interventions like propranolol and other beta blockers for the treatment of ulcerated infantile hemangiomas. Learn more about the study and whether features in patients and/or hemangiomas can help predict how long an ulceration might take to heal.
Esteban Fernández Faith, MD
Dr. Fernandez Faith is Assistant Professor of Pediatrics and Dermatology at the Ohio State University and Program Director of the Pediatric Dermatology Fellowship at Nationwide Children’s Hospital.
This international, multicenter, retrospective, cross-sectional study of 481 pediatric patients revealed a gap in diagnosis, and that HS patients are likely to suffer from other comorbidities. Learn more about the study, recommendations for managing patients with HS, and recommendations for future research.
Irene Lara Corrales, MD
Dr. Lara Corrales is an Associate Professor of Pediatrics at the University of Toronto and a staff physician in Pediatric Dermatology at the Hospital for Sick Children in Toronto, Canada.